Methazolamide — Discount Pricing

Other medications in Ophthalmology

• Netarsudil
• Pegaptanib
• Phenylephrine Eye
• Pilocarpine
• Prednisolone Acetate
• Ranibizumab
• Tafluprost
• Timolol

About Methazolamide

Methazolamide is a medication primarily used to manage certain types of glaucoma by reducing pressure inside the eye. For individuals prescribed this important medication, understanding its role and potential costs is key. TheDrugClub is dedicated to helping members access their necessary prescriptions, including methazolamide, often at significant savings.

Methazolamide is a carbonic anhydrase inhibitor prescribed mainly for the treatment of glaucoma, a group of eye conditions that damage the optic nerve, often due to abnormally high pressure inside your eye (intraocular pressure, or IOP). Specifically, it's used to reduce this elevated IOP in chronic simple (open-angle) glaucoma and secondary glaucoma. By lowering eye pressure, methazolamide helps prevent further damage to the optic nerve, which can lead to vision loss if left untreated. It may be used alone or in conjunction with other glaucoma medications.

This medication works by inhibiting an enzyme called carbonic anhydrase. This enzyme is found in various parts of the body, including the ciliary body of the eye, which is responsible for producing aqueous humor – the fluid that fills the front part of your eye. By blocking carbonic anhydrase, methazolamide reduces the production of aqueous humor. Less fluid production leads to a decrease in the pressure inside the eye. This mechanism makes it an effective tool in managing glaucoma and protecting vision. It's important to take methazolamide as prescribed by your doctor to maintain consistent control over your intraocular pressure.

The cost of methazolamide can vary significantly based on several factors, including whether you are prescribed the generic

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Methazolamide is approved for (FDA label)

Methazolamide Tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

Source: Read the full FDA label on DailyMed. Label effective date: March 27, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Methazolamide (FDA label)

Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a “tingling” feeling in the extremities; hearing dysfunction or tinnitus; fatigue; malaise; loss of appetite; taste alteration; gastrointestinal disturbances such as nausea, vomiting, and diarrhea; polyuria; and occasional instances of drowsiness and confusion. Metabolic acidosis and electrolyte imbalance may occur. Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication. Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity, convulsions, and, rarely, crystalluria and renal calculi. Also see PRECAUTIONS: Information for Patients for possible reactions common to sulfonamide derivatives.

Source: FDA prescribing information (DailyMed). Set ID: 1698aa2d-a962-4bcc-8646-4fff532b645b. SPL document ID: 24212013-fd63-40f7-967d-5df7d0410c18. Label effective date: March 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Methazolamide (FDA label)

Methazolamide therapy is contraindicated in situations in which sodium and/or potassium serum levels are depressed, in cases of marked kidney or liver disease or dysfunction, in adrenal gland failure, and in hyperchloremic acidosis. In patients with cirrhosis, use may precipitate the development of hepatic encephalopathy. Long-term administration of methazolamide is contraindicated in patients with angle-closure glaucoma, since organic closure of the angle may occur in spite of lowered intraocular pressure.

Source: FDA prescribing information (DailyMed). Set ID: 1698aa2d-a962-4bcc-8646-4fff532b645b. SPL document ID: 24212013-fd63-40f7-967d-5df7d0410c18. Label effective date: March 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.